Citi analyst Joanne Wuensch maintained a Buy rating on Becton Dickinson (BDX – Research Report) today. The company’s shares closed last Friday at $229.85. Leverage the power of TipRanks' Smart ...

The BD Accuri™ C6 is a personal flow cytometer that brings flow cytometry within reach by being easy to use, simple to maintain, and affordable. The analytical power and versatility of today’s ...

The BD FACSVerse™ flow cytometer was engineered from the ground up to offer remarkable performance, flexibility, and ease of operation for research applications using up to 10 parameters.

Becton Dickinson (BDX) is a global medical technology company comprised of essentially two businesses: (i) MedTech, which consists of the BD Medical (medication delivery and management solutions ...

Business: Becton Dickinson develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products for health-care institutions, physicians, life science ...

NEW ORLEANS − Eagles right guard Mekhi Becton left the game early in the second quarter with a knee injury. He was listed as questionable to return. The Eagles were leading the Chiefs 7-0 in the ...

Becton (knee) returned in the second quarter of Sunday's Super Bowl LIX bout against Kansas City, Dave Zangaro of NBC Sports Philadelphia reports. Becton suffered a knee injury early in the second ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...